FW: CIMI WG

3 views
Skip to first unread message

Stan Huff

unread,
Oct 15, 2015, 6:48:16 PM10/15/15
to cimi-modelli...@googlegroups.com, Dennis Giokas (dgiokas@infoway-inforoute.ca), Jamie Ferguson (Jamie.Ferguson@kp.org), Jane Millar, Nicholas Oughtibridge (UK), Stan Huff, Tom Jones, Virginia Riehl

Folks,

   Please see the note below.  Please subscribe.  As soon as everyone has moved over we will start using this list server for CIMI business.  Thanks, Stan

 

From: Karen Van Hentenryck (HL7) [mailto:kare...@hl7.org]
Sent: Thursday, October 15, 2015 8:48 AM
To: Stan Huff
Subject: Re: CIMI WG

 

Yes there is a listserv: cimi@ li...@hl7.org. People can either subscribe themselves or you can send us the list of names/ email addresses to subscribe


From: Stan Huff <Stan...@imail.org>
Sent: Wednesday, October 14, 2015 11:54:29 PM
To: Karen Van Hentenryck (HL7)
Subject: CIMI WG

 

Karen,

    Do we have a CIMI WG list server or mailing list yet?  Is there anything I need to do to get things set up?  Thanks, Stan


No virus found in this message.
Checked by AVG - www.avg.com
Version: 2014.0.4830 / Virus Database: 4365/10727 - Release Date: 09/29/15
Internal Virus Database is out of date.

William Goossen R4C

unread,
Oct 16, 2015, 12:21:24 AM10/16/15
to cimi-modelli...@googlegroups.com, ci...@lists.hl7.org
Hi all,

Great, a nice and concrete step!

Anneke and myself are subscribed to the HL7 list.

However, the proper address is

ci...@lists.hl7.org
so a . instead of @
Met vriendelijke groet / With kind regards,

dr. William T.F. Goossen
 
directeur Results 4 Care B.V.
De Stinse 15
3823 VM Amersfoort
the Netherlands

phone: +31654614458
e-mail: wgoo...@results4care.nl
skype: williamgoossenmobiel
kamer van koophandel 32133713
http://www.results4care.nl
http://www.results4care.eu
http://www.linkedin.com/company/711047
--
You received this message because you are subscribed to the Google Groups "cimi-modelling-taskforce" group.
To unsubscribe from this group and stop receiving emails from it, send an email to cimi-modelling-tas...@googlegroups.com.
To post to this group, send email to cimi-modelli...@googlegroups.com.
Visit this group at http://groups.google.com/group/cimi-modelling-taskforce.
For more options, visit https://groups.google.com/d/optout.

Patrick Langford

unread,
Oct 19, 2015, 12:46:40 PM10/19/15
to cimi-modelli...@googlegroups.com
Hey Everyone,

I was looking for information on how to subscribe to HL7 mailing lists and found this URL where you can subscribe to any of the lists… and CIMI is on the list.


Sincerely,
Patrick Langford

[:: NeuronSong, LLC ::] [:: Technology Consulting ::]
[:: (mobile) 801.597.1065 ::] [:: (fax) 888.230.6327 ::]





Gerard Freriks

unread,
Oct 20, 2015, 6:39:16 PM10/20/15
to cimi-modelli...@googlegroups.com, Dennis Giokas (dgiokas@infoway-inforoute.ca), James Ferguson, Jane Millar, Nicholas Oughtibridge (UK), Stan Huff, Tom Jones, Virginia Riehl
Dear all,

The topic of this e-mail is: the annotation of archetype nodes.

Thomas is investigating changes in the AOM v2 to be able to annotate nodes in archetypes end indicate the function of that node.
The problem is that all nodes have names and that these various names do not indicate what the focus of the archetype is and where the result can be found in the archetype. In essence CIMI models are clinical statements that have a subject and a result plus additional data, the contextual information and modifiers and classifiers.
The function and relationship between nodes in archetypes is usually not explicit. Humans that look at archetypes can make inferences and find the subject and result of the statements and the other components.

One common way to make the function of each archetype node clear is to annotate each node explicitly.
The CEN ISO 13606 allows to record per node the used name for that node and zero or more annotating codes.
It is therefor unclear to me why AOM is needed to create this annotation feature.

In addition I’m of the opinion that when the CIMI Clinical Model is modelled by using a specific (other) modeling style much of the meaning of the node and their relationships are made explicit. When each CIMI Clinical model is using a fixed pattern to model any Subject, any Result, any contextual data, any modifier or qualifier then each node always has the same meaning and is the relationship between nodes explicit.
This Attribute modeling style results in Archetypes that are specialized by changing one or more attribute data fields, constraints and by adding additional nodes. The Class modeling style specialists by changing names of nodes.
When in archetypes, that follow the Attribute modeling style, in addition these notes are annotated using ‘primitives’ from a reference terminology, then archetypes are modeling concepts using well defined nodes.

When the major aim of CIMI is to produce archetypes (Clinical Models) for interoperability between two parties then the Class modeling style is sufficient.

When the major aim of CIMI is to produce archetypes (Clinical Models) for interpretability, for use annex rules engines, the Attribute modeling style solve a problem. Rules engines ‘know’ exactly what the function of each node is and what their relationship is. No longer Node names are important, or atCodes, but the fixed pattern and annotation codes from a reference terminology are important.

One thing is clear. Using the Attribute modeling style fixes a large part of the Archetype in a standard pattern. Some aspects will never be standard and fixed. These aspects deal with the Method and Confounding factors that describe part of the epistemology of the clinical statement.
Reply all
Reply to author
Forward
0 new messages